Abstract
In a double-blind, placebo-controlled study, we used 1H MR spectroscopy to assess the effect of a single infusion of sodium dichloroacetate on lesion lactate 1 to 5 days after ischemic stroke. Apparent trends toward a reduction in lactate/N-acetyl compound ratios were seen at the higher drug doses employed, and in patients treated in the first 2 days following infarction. Use of spectroscopic measures as endpoints is feasible in acute stroke clinical trials.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1376-1378 |
| Number of pages | 3 |
| Journal | Neurology |
| Volume | 55 |
| Issue number | 9 |
| DOIs | |
| State | Published - Nov 14 2000 |
| Externally published | Yes |
ASJC Scopus subject areas
- Clinical Neurology
Fingerprint
Dive into the research topics of 'MR spectroscopy study of dichloroacetate treatment after ischemic stroke'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS